Pfizer: JAK Inhibitors for the Treatment of Patients With Rheumatoid Arthritis (RA): Learnings from Real World Experience


Barnes

Satellite Symposium
05 June 2020 08:15 - 09:15

  • Highlight the importance of real-world data as part of the totality of evidence for medical therapies  

  • Explore the available real-world evidence for JAK inhibitors in the management of patients with RA  

     

The Value of Real-World Data

  • Describe the need for real-world data and how they add to data collected from clinical trials
  • Explore different real-world data sources, and their relative strengths and limitations

 

 

Effectiveness and Persistence of JAK Inhibitors in Patients With RA Treated in the Real World

  • Highlight the use of effectiveness and persistence data in real-world studies to support evolving patient needs in patients with RA

 

Safety of JAK Inhibitors in the Real World in Patients With RA

  • Discuss the evidence for the safety profile of JAK inhibitors in real-world studies in patients with RA, and the implication on treatment strategies

Presentations

Title Time Add to calendar
Pfizer Symposium
05 June 2020 08:15 - 08:15 Add to calendar
Welcome and Faculty Introductions
05 June 2020 08:15 - 08:20 Add to calendar
The Value of Real-World Data
05 June 2020 08:20 - 08:30 Add to calendar
Effectiveness and Persistence of JAK Inhibitors in Patients With RA Treated in the Real World
05 June 2020 08:30 - 08:40 Add to calendar
Safety of JAK Inhibitors in the Real World in Patients With RA
05 June 2020 08:40 - 08:55 Add to calendar
Summary and Close
05 June 2020 08:55 - 09:00 Add to calendar